Clinical Trials · NCT02344550
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Asan Medical Center
- Enrollment
- 137
- Start date
- Jan 2014
- Locations
- 1 site, South Korea
- Primary endpoint
- Progression free survival (PFS)